AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Letsita-M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Lekasa Health Care Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Letsita-M 50/500 Tablet

Combiflex-D 50/500 tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. Combiflex-D 50/500 may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and current medications. Ingesting it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under medical supervision. Adherence to your physician's dietary and exercise plan is crucial. Lifestyle significantly impacts diabetes control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, especially when used with insulin or sulfonylureas; learn its symptoms and management. This medication isn't for everyone. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic issues, or excessive alcohol consumption before starting. Pregnant or lactating individuals should seek medical counsel. Interactions with other drugs are possible; disclose all medications to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your physician will monitor kidney function and glucose levels throughout your treatment.

Primary Ingredients of Letsita-M 50/500 Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Letsita-M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Letsita-M 50/500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Letsita-M 50/500 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Letsita-M 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Letsita-M 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Letsita-M 50/500 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Letsita-M 50/500 Tablet works:

Letsita-M 50/500 tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Letsita-M 50/500 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Letsita-M 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Letsita-M 50/500 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Letsita-M 50/500 Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Letsita-M 50/500 Tablets are contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of Letsita-M 50/500 Tablets is potentially hazardous for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Letsita-M 50/500 Tablet :

Should you forget a Letsita-M 50/500 Tablet dose, administer it promptly. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Letsita-M 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Letsita-M 50/500 Tablet

Letsita-M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Letsita-M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as numbness, tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Letsita-M 50/500 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Letsita-M 50/500 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Letsita-M 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the label's storage instructions. Discard any unused medication and keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Letsita-M 50/500 Tablet. This occurs due to excess lactic acid in the blood and is rare, but avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Letsita-M 50/500 Tablet and seek immediate medical attention.
Letsita-M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Letsita-M 50/500 Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients allergic to Letsita-M 50/500 Tablet components or excipients should not use it. Its use is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Letsita-M 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Metformin, a component of Letsita-M 50/500 Tablet, can cause lactic acidosis (MALA), a serious medical emergency involving high blood lactic acid levels. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Letsita-M 50/500 Tablet and seek immediate medical attention.
Prolonged use of Letsita-M 50/500 Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes, including balance problems (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Letsita-M 50/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. It enhances blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity; sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Letsita-M 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Letsita-M 50/500 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Letsita-M 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid, is a potential side effect of Letsita-M 50/500 Tablet (also known as Metformin-associated lactic acidosis, or MALA). While rare, this risk is heightened in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Letsita-M 50/500 and seek immediate medical attention.
Prolonged use of Letsita-M 50/500 Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance issues), urinary problems, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Letsita-M 50/500 Tablet
155
MRP 180
13% off